Q4 2023 · 13F-HR
Bill & Melinda Gates Foundationholdings as filed
Filed 2024-02-14 · accession 0000898432-24-000131
$89.9M
Reported value
8
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 45258D105 | IMCR | IMMUNCORE HLDGS PLC | $39.4M | 43.9% | 576,923 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $15.7M | 17.5% | 148,674 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $15.7M | 17.4% | 1,559,142 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA | $10.2M | 11.3% | 1,590,909 | Common | SOLE |
| N2451R105 | CVAC | CUREVAC N V | $6.8M | 7.60% | 1,625,943 | Common | SOLE |
| 124155102 | BFLY | BUTTERFLY NETWORK INC | $1.1M | 1.21% | 1,011,003 | Common | SOLE |
| G5709L109 | — | LUMIRADX LTD | $857,143 | 0.95% | 14,285,714 | Common | SOLE |
| 04965G109 | BCELUSD | ATRECA INC | $118,643 | 0.13% | 912,642 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.